Stephen Hahn

Directeur/Membre du Conseil chez ION BEAM APPLICATIONS, SA

Health Technology

Consumer Services

Profil

Mr. Stephen M.
Hahn is a Chief Executive Officer at Nucleus Radiopharma, Inc. He is on the Board of Directors at Ion Beam Applications SA and Faeth Therapeutics, Inc. He received his undergraduate degree from William Marsh Rice University and a graduate degree from Temple University (Pennsylvania).

Postes actifs de Stephen Hahn

Sociétés	Poste	Début
ION BEAM APPLICATIONS, SA	Directeur/Membre du Conseil	16/06/2026
FAETH THERAPEUTICS, INC.	Directeur/Membre du Conseil	12/06/2026
Nucleus Radiopharma, Inc. Nucleus Radiopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a end-to-end contract development and manufacturing organization	Directeur Général	20/08/2025

Tous les postes actifs de Stephen Hahn

Formation de Stephen Hahn

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Stephen Hahn

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	5
Ion Beam Applications SA Ion Beam Applications SA Medical SpecialtiesHealth Technology Supplies medical, dental and hospital equipment	Health Technology
Rice University Rice University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Temple University (Pennsylvania) Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Sensei Biotherapeutics, Inc. Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease	Health Technology
Nucleus Radiopharma, Inc. Nucleus Radiopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a end-to-end contract development and manufacturing organization	Health Technology